Alan He supports clients with market access, reimbursement, and commercialization strategy.

Alan utilizes his experience across a variety of therapeutic categories and broad product focus to help clients navigate market challenges within the US healthcare environment.

 Prior to joining Avalere, Alan was a consultant at Precision Medicine Group, where he worked within the Global Pricing, Market Access, and Analytics group to develop pricing, contracting, and competitive defense strategies for pharmaceutical manufacturers and biotech companies.

 Alan holds a BS in management from Penn State University

Authored Content


The intersection of upcoming changes to drug pricing metrics will require new methods of calculating and reporting government pricing with implications for net pricing and contracting strategies.